Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Abstract
Imidazolopiperazine compounds inhibit liver-stage malaria parasites with one oral dose in mice.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Dec 09, 2011
- Source ID
- 10.1126/science.1211936
Entities
People
- A. Taylor Bright
- Advait Nagle
- Arnab Chatterjee
- Bin Zhou
- Case W. Mcnamara
- David A. Fidock
- David M. Plouffe
- Dominique Mazier
- Elizabeth Winzeler
- Ghislain M. C. Bonamy
- Jason Roland
- Jetsumon Sattabongkot
- Jianwei Che
- John R. Walker
- Kelli L. Kuhen
- Kerstin Gagaring
- Marcus C. S. Lee
- Matthias Rottmann
- Montip Gettayacamin
- Neekesh V. Dharia
- Nobutaka Kato
- Patrick Froissard
- Perry Gordon
- Peter G. Schultz
- Rachel Borboa
- Richard J. Glynne
- S. Whitney Barnes
- Selina E. Bopp
- Stephan Meister
- Steve Cohen
- Tae-gyu Nam
- Tao Wu
- Thierry T. Diagana
- Todd Groessl
- Tove Tuntland
- Wendy Richmond
- Yingyao Zhou
Organizations
- Armed Forces Research Institute of Medical Sciences
- Assistance Publique – Hôpitaux de Paris
- Columbia University
- French National Institute of Health and Medical Research
- Novartis
- Scripps Research
- Swiss Tropical and Public Health Institute
- University of Basel
- University of California, San Diego